Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Current Leases (2019 - 2025)

Historic Current Leases for Marimed (MRMD) over the last 7 years, with Q3 2025 value amounting to $2.2 million.

  • Marimed's Current Leases rose 1271.53% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 1271.53%. This contributed to the annual value of $2.0 million for FY2024, which is 375.32% up from last year.
  • Latest data reveals that Marimed reported Current Leases of $2.2 million as of Q3 2025, which was up 1271.53% from $2.0 million recorded in Q2 2025.
  • Over the past 5 years, Marimed's Current Leases peaked at $2.2 million during Q3 2025, and registered a low of $1.1 million during Q4 2021.
  • Moreover, its 5-year median value for Current Leases was $1.8 million (2023), whereas its average is $1.6 million.
  • Its Current Leases has fluctuated over the past 5 years, first fell by 14.26% in 2022, then skyrocketed by 5939.72% in 2023.
  • Quarter analysis of 5 years shows Marimed's Current Leases stood at $1.1 million in 2021, then increased by 18.86% to $1.3 million in 2022, then skyrocketed by 52.79% to $1.9 million in 2023, then rose by 3.75% to $2.0 million in 2024, then increased by 10.26% to $2.2 million in 2025.
  • Its Current Leases was $2.2 million in Q3 2025, compared to $2.0 million in Q2 2025 and $2.1 million in Q1 2025.